{"id":"W4283578471","doi":"10.1093/jncics/pkac047","title":"Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JNCI Cancer Spectrum","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Canadian Partnership Against Cancer; St. Michael's Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; University of Toronto; Queen's University; Women's College Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Cost effectiveness; Internal medicine; Propensity score matching; Oncology; Pancreatic cancer; Irinotecan; Folinic acid; Randomized controlled trial; Cancer; Fluorouracil; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006345767,0.0003413972,0.001414726,0.0004618531,0.0001912756,0.000008551274,0.0002633244,0.00007733056,0.002038464],"category_scores_gemma":[0.00009731837,0.0002863378,0.000115454,0.001335256,0.0002133854,0.0001178531,0.0002048845,0.0006435694,0.000006329598],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004007454,"about_ca_system_score_gemma":0.001281943,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01965837,"about_ca_topic_score_gemma":0.01600525,"domain_scores_codex":[0.9967672,0.0002833487,0.0005883863,0.0006204936,0.0009473302,0.00079324],"domain_scores_gemma":[0.9982089,0.0004619372,0.0002897031,0.0006065188,0.0001990652,0.0002338781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01856486,0.0007574093,0.975352,0.0007201175,0.0003194609,0.00007883245,0.000325796,0.00178919,0.00008589793,0.0002364069,0.0002271266,0.001542897],"study_design_scores_gemma":[0.01907535,0.0035469,0.9726748,0.0006729803,0.0003134736,0.000005240644,0.0001018863,0.001015515,0.0005835688,0.000233323,0.001481698,0.0002952995],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903693,0.0009345592,0.00005227809,0.001169662,0.0003082368,0.003421115,0.000251961,0.00005388973,0.003439028],"genre_scores_gemma":[0.9921004,0.001036958,0.0001979562,0.0001582692,0.0001289426,0.003908811,0.00009847515,0.00007192749,0.002298218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003653115,"threshold_uncertainty_score":0.9999589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0251690455597906,"score_gpt":0.34760438122919,"score_spread":0.3224353356693994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}